Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Specialklinikken Borgå ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.8% 0.8%   Bankruptcy risk   2.4% 2.2% 1.9% 2.0% 2.2% 1.5% 10.9% 10.9%   Credit score (0-100)   65 67 71 68 65 75 22 22   Credit rating   BBB BBB A A BBB A BB BB   Credit limit (kDKK)   0.0 0.0 0.4 0.2 0.0 7.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,556 1,266 1,817 1,659 1,402 1,404 0.0 0.0   EBITDA   610 493 787 589 323 804 0.0 0.0   EBIT   436 295 546 345 118 673 0.0 0.0   Pre-tax profit (PTP)   313.9 163.7 392.3 273.2 243.3 497.4 0.0 0.0   Net earnings   237.6 115.9 296.0 206.0 189.4 376.3 0.0 0.0   Pre-tax profit without non-rec. items   314 164 392 273 243 497 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   4,140 4,415 4,243 4,248 4,499 4,659 0.0 0.0   Shareholders equity total   415 478 718 868 1,000 1,317 1,131 1,131   Interest-bearing liabilities   3,222 3,407 2,906 2,761 3,001 2,838 0.0 0.0   Balance sheet total (assets)   4,163 4,518 4,351 4,316 4,808 4,876 1,131 1,131   Net Debt   3,219 3,400 2,905 2,761 2,977 2,838 -1,131 -1,131     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,556 1,266 1,817 1,659 1,402 1,404 0.0 0.0   Gross profit growth   6.9% -18.7% 43.6% -8.7% -15.5% 0.1% -100.0% 0.0%   Employees   2 2 2 2 2 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% -50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,163 4,518 4,351 4,316 4,808 4,876 1,131 1,131   Balance sheet change%   -4.7% 8.5% -3.7% -0.8% 11.4% 1.4% -76.8% 0.0%   Added value   610.1 493.1 787.4 589.0 361.7 804.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -324 78 -413 -238 46 28 -4,659 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.0% 23.3% 30.1% 20.8% 8.4% 47.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.2% 6.8% 12.3% 8.0% 9.1% 13.9% 0.0% 0.0%   ROI %   11.6% 7.8% 14.4% 9.5% 10.8% 16.5% 0.0% 0.0%   ROE %   80.4% 26.0% 49.5% 26.0% 20.3% 32.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   10.0% 10.6% 16.5% 20.1% 20.8% 27.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   527.6% 689.5% 369.0% 468.7% 920.7% 352.9% 0.0% 0.0%   Gearing %   777.2% 713.5% 404.6% 318.1% 300.1% 215.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.6% 4.0% 4.9% 2.6% 5.9% 6.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0   Current Ratio   0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0   Cash and cash equivalent   3.0 7.0 0.3 0.0 23.5 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -969.5 -1,106.8 -916.1 -987.5 -1,040.6 -901.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   305 247 394 294 181 804 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   305 247 394 294 162 804 0 0   EBIT / employee   218 148 273 173 59 673 0 0   Net earnings / employee   119 58 148 103 95 376 0 0